Topically administered corticosteroids are widely used in treating a large range of inflammatory and allergic eye conditions. But their use has been partially limited after Armaly' reported the increase in intraocular pressure (IOP) produced by locally instilled corticosteroids. The 'corticosteroid It should be noted that the average initial lOP found in our children was 11-2 ±2-0, which is below the accepted normal IOP in adults 16-0±3-0.4 This finding might explain the lower steroid response in children than in normal adults, as a higher initial LOP is expected later in life. This may produce an increase in the steroid responsiveness also.
Although these 3 groups were differentiated on the basis of the magnitude of pressure rise, the time of pressure rise was also different, and it is of clinical significance. Group 1, the low responders, showed a slight pressure rise at the end of 2 weeks, and the pressure remained stabilised afterwards. In groups 2 and 3 (11 %) the pressure rose continuously with further treatment. The clinical implication of this is that a child who has received topical corticosteroid treatment for a month but still has pressures below 21 mmHg is unlikely to have a further increase in his or her intraocular pressure. Should the pressure be above 21 mmHg at the end of the first month, subsequent steroid therapy should include careful monitoring of the intraocular pressure.
These results do not differ substantially from previously reported observations on time-dependent IOP raised in normal adults. ' We thank Mrs Bilha Savell for her technical assistance.
